Randox Korea is improving healthcare using innovative diagnostics technologies, for a range of health conditions including heart disease, diabetes, Alzheimer’s disease, cancer and stroke. Around 70% of all medical decisions are based on laboratory results, and so, not surprisingly, we believe that earlier, more accurate and more accessible diagnostics are the key to improving global health and saving lives.
Our range of Serology Quality Controls is designed to deliver a cost effective, high quality solution for the routine performance monitoring of a variety of infectious diseases whilst producing trustworthy results time and time again. Comprising a wide range of infectious diseases including; HIV, Hepatitis, Epstein Barr Virus (EBV), ToRCH, Lyme Disease and SARS-CoV-2, our third party serology quality controls will ensure unbiased performance assessment and are compatible for use with some of the most popular immunoassay platforms including Roche, Abbott, Siemens & Beckman systems among others. Conveniently supplied in a user-friendly, liquid ready-to-use format no preparation is required, an extended open vial stability ensures waste is kept to a minimum. A range of multi-analyte reactive and non reactive controls are available, reducing the number of individual controls required to cover your test menu. All of our Serology controls have gained CE marking.